Skip to main content

Primary Biliary Cholangitis clinical trials at UCSF

1 research study open to eligible people

Primary biliary cholangitis is a chronic disease causing the liver ducts to become inflamed and damaged. UCSF is running trials to test the effectiveness of Seladelpar on liver health in patients with this condition and compensated cirrhosis. The trials examine how the medication impacts clinical outcomes over time.

Showing trials for

Last updated: